The Latest Cardiac and Vascular News
Large-scale NHS trial led by Imperial College London across 200+ NHS practices shows significant gains in early cardiac disease detection through AI-assisted stethoscope exams SAN FRANCISCO, Jan. 29, 2026 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary disease…
Landmark TRICORDER study finds major gains in detection of heart failure, atrial fibrillation, and valvular disease with Eko Health’s AI-enabled stethoscopes in routine exams. SAN FRANCISCO, Sept. 11, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary disease…
Former U.S. Surgeon General will help guide Eko’s mission to expand access to AI-powered cardiac screening and early detection worldwide SAN FRANCISCO, Aug. 21, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary detection, today announced that Jerome Adams, MD,…
Expansion brings together top clinical leaders to help scale Eko’s disease detection platform following major FDA clearances, reimbursement wins, and peer-reviewed publications SAN FRANCISCO, Aug. 6, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced the expansion of its Clinical Advisory Board to support the company’s mission […]
Live-streaming high-fidelity heart and lung sounds sets a new standard for virtual care, modernized with web-based access and enterprise integration SAN FRANCISCO, July 15, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced today that its…
CPT Code for AI-Enabled Cardiac Analysis, Issued by the American Medical Association (AMA), Also Takes Effect July 1, 2025 SAN FRANCISCO, July 1, 2025 /PRNewswire/ — Eko Health, a leader in AI-powered cardiac and pulmonary care, announced a major step forward in expanding access to early…
Healthcare professionals across Canada can now access Eko’s most advanced digital stethoscope and AI-powered membership to enhance cardiac and pulmonary care. SAN FRANCISCO, April 9, 2025 /PRNewswire/ — Eko Health, a leader in applying artificial intelligence (AI) for the early detection…
Published in the Journal of the American College of Cardiology (JACC) Advances, the study highlights the potential of Eko’s platform to aid in detecting reduced ejection fraction (EF), a key indicator of heart failure. SAN FRANCISCO, March 3, 2025 /PRNewswire/ — Eko Health, a leader in…
Patients identified with reduced ejection fraction using Eko Health AI were twice as likely to experience heart attacks, heart failure, hospitalization, and all-cause mortality over two years. SAN FRANCISCO, Oct. 2, 2024 /PRNewswire/ — Eko Health, a pioneer in applying artificial…
Eko Health outfits LSU Athletic Sports Medicine team with CORE 500 digital stethoscopes and AI algorithms for the enhanced detection of cardiac conditions during athlete physical exams BATON ROUGE, La. & SAN FRANCISCO, Aug. 8, 2024 /PRNewswire/ — Eko Health, a pioneer in applying…
